Profile data is unavailable for this security.
About the company
Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin formulations for the treatment of diabetes: two formulations of insulin analog lispro (BioChaperone Lispro U100 and U200), a combination of basal insulin glargine and insulin lispro (BioChaperone Combo), and a combination of prandial insulin with amylin analog pramlintide: M1Pram. Its preclinical pipeline includes three products BioChaperone LisPram, BioChaperone Glargine GLP-1 and BioChaperone Glucagon GLP1.
- Revenue in EUR (TTM)2.15m
- Net income in EUR-21.16m
- Incorporated2006
- Employees78.00
- LocationAdocia SA115 avenue LacassagneLYON 69003FranceFRA
- Phone+33 472610610
- Fax+33 472363967
- Websitehttps://www.adocia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Poolbeg Pharma PLC | 0.00 | -4.66m | 74.69m | 8.00 | -- | 4.36 | -- | -- | -0.0079 | -0.0079 | 0.00 | 0.0289 | 0.00 | -- | -- | 0.00 | -22.65 | -- | -24.00 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 16.11 | -- | -- | -- |
Anatolia TaniveBytklj Unli Ar Ge SiveTiA | 8.54m | -5.84m | 77.17m | 229.00 | -- | 2.10 | -- | 9.04 | -0.5563 | -0.5563 | 1.85 | 5.98 | 0.2549 | 0.3473 | 4.29 | 1,490,227.00 | -17.42 | 16.60 | -18.36 | 17.72 | 80.55 | 85.88 | -68.34 | 39.69 | 5.78 | -- | 0.0142 | -- | -49.14 | 72.60 | -548.82 | -- | 65.06 | -- |
Captor Therapeutics SA | 3.78m | -15.39m | 77.79m | 104.00 | -- | 6.13 | -- | 20.58 | -15.07 | -15.07 | 3.63 | 12.86 | 0.1741 | -- | 5.14 | 155,413.50 | -70.87 | -- | -89.64 | -- | 54.29 | -- | -407.07 | -- | -- | -- | 0.0458 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
Alligator Bioscience AB | 3.89m | -19.96m | 87.81m | 51.00 | -- | -- | -- | 22.56 | -0.362 | -0.362 | 0.0696 | -0.0125 | 0.2653 | -- | 9.47 | 788,034.50 | -136.02 | -73.26 | -367.94 | -91.33 | -- | -- | -512.61 | -811.68 | -- | -35.61 | 5.17 | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
BenevolentAI SA | 8.69m | -75.07m | 92.75m | 248.00 | -- | 0.7095 | -- | 10.67 | -0.6371 | -0.6371 | 0.0737 | 0.9166 | 0.0473 | -- | 0.3631 | 35,046.57 | -40.88 | -- | -48.87 | -- | -- | -- | -863.69 | -- | -- | -- | 0.048 | -- | -30.58 | -- | 61.38 | -- | -- | -- |
Adocia SA | 2.15m | -21.16m | 96.58m | 78.00 | -- | -- | -- | 44.92 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
Eurofins-Cerep SA | 44.07m | 7.64m | 99.37m | 228.00 | 13.01 | 1.54 | 10.34 | 2.25 | 1,514.43 | 1,514.43 | 8,743.94 | 12,820.37 | 0.5864 | 1.67 | 5.08 | 193,287.10 | 10.16 | 14.21 | 12.22 | 17.51 | 85.01 | 73.61 | 17.33 | 19.77 | 4.87 | -- | 0.00005 | -- | -7.47 | 11.60 | -33.72 | 14.64 | -- | -- |
Maat Pharma SA | 2.23m | -19.72m | 104.39m | 50.00 | -- | 4.26 | -- | 46.85 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
Arcticzymes Technologies ASA | 9.84m | 1.47m | 105.39m | 68.00 | 71.73 | 4.01 | 52.91 | 10.71 | 0.3443 | 0.3443 | 2.30 | 6.17 | 0.3562 | 0.4228 | 6.29 | 1,731,471.00 | 5.31 | 15.58 | 5.66 | 17.22 | 95.50 | 96.69 | 14.91 | 33.23 | 12.14 | -- | 0.0327 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
Transgene SA | 7.63m | -22.33m | 107.48m | 158.00 | -- | 6.83 | -- | 14.08 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
Scope Fluidics SA | 21.75k | -5.29m | 110.05m | 40.00 | -- | 6.35 | -- | 5,059.09 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
Medica SpA | 79.98m | 2.97m | 114.87m | 731.00 | 38.72 | 2.21 | 12.06 | 1.44 | 0.7025 | 0.7025 | 18.94 | 12.33 | 0.6417 | 1.39 | 5.00 | 109,410.10 | 2.00 | 4.26 | 3.17 | 6.34 | 59.45 | 63.25 | 3.12 | 7.16 | 0.8734 | 3.88 | 0.307 | -- | 57.24 | 19.52 | -31.80 | 2.05 | 24.28 | -- |
Inventiva SA | 17.48m | -110.43m | 117.81m | 112.00 | -- | -- | -- | 6.74 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
Oryzon Genomics SA | 0.00 | -2.87m | 120.09m | 44.00 | -- | 1.40 | -- | -- | -0.0431 | -0.0431 | 0.00 | 1.34 | 0.00 | 101.09 | -- | 0.00 | -2.72 | -4.20 | -3.19 | -4.82 | -- | -- | -- | -- | 0.8741 | -3.16 | 0.1487 | -- | -- | -- | 20.76 | -- | 15.52 | -- |
Futura Medical PLC | 3.68m | -7.72m | 121.05m | 12.00 | -- | 18.61 | -- | 32.93 | -0.0219 | -0.0219 | 0.0105 | 0.0182 | 0.3391 | -- | 5.09 | 258,414.20 | -71.22 | -79.25 | -127.75 | -127.22 | 57.22 | -- | -210.03 | -914.37 | 1.47 | -- | 0.00 | -- | -- | -- | -11.40 | -- | 219.68 | -- |
Holder | Shares | % Held |
---|---|---|
Uzes Gestion SAas of 28 Jun 2024 | 30.00k | 0.20% |
Gestys SAas of 26 Jan 2024 | 1.10k | 0.01% |
CGM � Azimut Monaco SAas of 31 May 2024 | 0.00 | 0.00% |
Iris Finance SAas of 31 Dec 2018 | 0.00 | 0.00% |